L.I.A. Pure Capital Ltd → Evogene Ltd. EVGN

Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On July 26, 2026, the Reporting Persons delivered an email to the Issuer in response to communications received from the Issuer regarding the Demand Letter previously disclosed in the Schedule 13D. In the email, the Reporting Persons reiterated their demand that the Issuer convene a special general meeting of shareholders, rejected certain settlement proposals discussed by the Issuer, reaffirmed their intention to pursue the matters described in the Demand Letter, and reserved all rights available to them under applicable law. The Reporting Persons also requested that the Issuer provide drafts of meeting and proxy materials relating to the requested special general meeting. A copy of such email is attached hereto as Exhibit 4 and is incorporated herein by reference.